Attached files

file filename
EX-99.2 - EXHIBIT 99.2 Q3 2017 EARNINGS PRESENTATION - TCF FINANCIAL CORPa2017q3earningscallprese.htm
8-K - 8-K CHFC Q3 2017 EARNINGS RELEASE - TCF FINANCIAL CORPchfc8-k2017q3.htm

Exhibit 99.1

For further information:
David T. Provost, CEO
Dennis L. Klaeser, CFO
989-839-5350

Chemical Financial Corporation Reports 2017 Third Quarter Operating Results
MIDLAND, MI, October 24, 2017 -- Chemical Financial Corporation ("Corporation" or "Chemical") (NASDAQ:CHFC) today announced 2017 third quarter net income of $40.5 million, or $0.56 per diluted share, compared to 2017 second quarter net income of $52.0 million, or $0.73 per diluted share and 2016 third quarter net income of $11.5 million, or $0.23 per diluted share. Excluding merger and restructuring expenses and the change in fair value in loan servicing rights ("significant items"), net income in the third quarter of 2017 was $56.9 million, or $0.79 per diluted share, compared to $53.5 million, or $0.75 per diluted share, in the second quarter of 2017 and $37.4 million, or $0.75 per diluted share, in the third quarter of 2016.(1)
During the third quarter of 2017, significant items included restructuring expenses of $18.8 million, merger expenses of $2.4 million and a $4.0 million detriment to earnings due to the change in fair value in loan servicing rights, compared to merger expenses of $0.5 million and a $1.8 million detriment to earnings due to the change in fair value in loan servicing rights in the second quarter of 2017. The restructuring expenses incurred during the third quarter of 2017 were a result of the Corporation's previously announced restructuring efforts, consisting primarily of severance and retirement related expenses. The third quarter of 2016 included $37.5 million of merger expenses and a $1.2 million detriment to earnings due to the change in fair value in loan servicing rights.
"We are pleased with our core underlying trends this quarter, including increased net interest income, improved operating efficiency and a stable net interest margin," noted David T. Provost, Chief Executive Officer of Chemical Financial Corporation and Thomas C. Shafer, Vice Chairman of the Corporation and Chief Executive Officer of Chemical Bank. "With the enhancements we have made in the third quarter of 2017 in association with our restructuring efforts, we believe we are on target to achieve the long-term growth prospects established as part of our most recent merger performance targets."
The Corporation's return on average assets was 0.86% during the third quarter of 2017, compared to 1.14% during the second quarter of 2017 and 0.37% in the third quarter of 2016. The Corporation's return on average shareholders' equity was 6.1% in the third quarter of 2017, compared to 8.0% during the second quarter of 2017 and 2.9% in the third quarter of 2016. Excluding significant items, the Corporation's return on average assets was 1.21% during the third quarter of 2017, compared to 1.17% during the second quarter of 2017 and 1.22% in the third quarter of 2016 and, excluding significant items, the Corporation's return on average shareholders' equity was 8.6% in the third quarter of 2017, compared to 8.2% during the second quarter of 2017 and 9.6% in the third quarter of 2016. The Corporation's return on average tangible shareholders' equity was 10.9% in the third quarter of 2017, compared to 14.3% during the second quarter of 2017 and 4.7% in the third quarter of 2016. Excluding significant items, the Corporation's return on average tangible equity was 15.3% in the third quarter of 2017, compared to 14.7% during the second quarter of 2017 and 15.4% in the third quarter of 2016.(2) 
Net interest income was $143.6 million in the third quarter of 2017, $5.7 million, or 4.1%, higher than the second quarter of 2017 and $46.8 million, or 48.4%, higher than the third quarter of 2016. The higher net interest income in the third quarter of 2017 compared to the second quarter of 2017 was driven by the positive impact of organic loan growth, an increase in the investment securities portfolio, improvement in yields on loans, and one additional day in the quarter. These benefits to net interest income were partially offset by the interest expense impact of increases in average deposits and short-term borrowings. The increase in net interest income in the third quarter of 2017 over the third quarter of 2016 was primarily attributable to organic loan growth and loans acquired in the merger with Talmer Bancorp, Inc. ("Talmer"). The Corporation experienced net organic loan growth of $166.0 million during the third quarter of 2017 and $1.12 billion during the twelve months ended September 30, 2017. The merger with Talmer added $4.88 billion of loans on August 31, 2016.
The net interest margin was 3.40% in the third quarter of 2017, compared to 3.41% in the second quarter of 2017 and 3.49% in the third quarter of 2016. The net interest margin (on a tax-equivalent basis) was 3.48% in both the third quarter of 2017 and second quarter of 2017, compared to 3.58% in the third quarter of 2016.(3) The net interest

1


margin (on a tax-equivalent basis) in the third quarter of 2017, compared to the second quarter of 2017, was compressed due to an increase in the investment securities portfolio funded by an increase in average borrowings and time deposits. This compression was offset by an increase of 9 basis points in yield on total loans in the third quarter of 2017 to 4.31%, compared to the second quarter of 2017, primarily due to higher yields on originated loans and the benefit from interest rate adjustments on variable rate loans during the third quarter of 2017.
The provision for loan losses was $5.5 million in the third quarter of 2017, compared to $6.2 million in the second quarter of 2017 and $4.1 million in the third quarter of 2016. The decrease in the provision for loan losses in the third quarter of 2017, compared to the second quarter of 2017, was primarily the result of a lower amount of net organic loan growth in addition to improvements in collateral position of loans that are individually evaluated for impairment, partially offset by $0.6 million of impairment recorded during the third quarter of 2017 as a result of the quarterly re-estimation of cash flows of the acquired loan portfolio. The increase in provision for loan losses in the third quarter of 2017, compared to the third quarter of 2016, was primarily the result of an increase in originated loan growth. Originated loan growth was $496.5 million in the third quarter of 2017, compared to $699.9 million in the second quarter of 2017 and $377.0 million in the third quarter of 2016. The growth in the originated loan portfolio was partially offset by run-off in the acquired loan portfolio of $330.5 million in the third quarter of 2017, compared to $305.9 million in the second quarter of 2017 and $190.9 million in the third quarter of 2016. All acquired loans were recorded at their estimated fair value at each respective acquisition date without a carryover of the related allowance and, as of September 30, 2017, the allowance recorded for this population of loans was $0.6 million, reflecting impairment recorded during the third quarter of 2017.
Net loan charge-offs were $3.5 million, or 0.10% of average loans, in the third quarter of 2017, compared to $1.2 million, or 0.04% of average loans, in the second quarter of 2017 and $1.8 million, or 0.08% of average loans, in the third quarter of 2016. The increase in charge-offs in the third quarter of 2017 was primarily due to one commercial loan relationship.
The Corporation's nonperforming loans totaled $54.3 million at September 30, 2017, compared to $50.9 million at June 30, 2017 and $41.3 million at September 30, 2016. Nonperforming loans comprised 0.39% of total loans at September 30, 2017, compared to 0.37% at June 30, 2017 and 0.32% at September 30, 2016. The increase in the percentage of nonperforming loans to total loans at September 30, 2017, compared to June 30, 2017, was primarily due to an increase in commercial real estate nonaccrual loans.
At September 30, 2017, the allowance for loan losses was $85.8 million, including $85.2 million for the originated loan portfolio and $0.6 million for the acquired loan portfolio. The allowance for loan losses for the originated loan portfolio was $85.2 million, or 0.93% of originated loans at September 30, 2017, compared to $83.8 million, or 0.97% of originated loans, at June 30, 2017 and $73.8 million, or 1.09% of originated loans, at September 30, 2016. The reduction in the allowance for loan losses as a percentage of originated loans primarily reflects improvement in collateral position of loans individually evaluated for impairment. The allowance for loan losses of the originated loan portfolio as a percentage of nonperforming loans was 156.9% at September 30, 2017, compared to 164.7% at June 30, 2017 and 178.6% at September 30, 2016. The allowance for loan losses for the acquired loan portfolio of $0.6 million was established during the third quarter of 2017 due to impairment identified in the quarterly re-estimation of cash flows.
Noninterest income was $32.1 million in the third quarter of 2017, compared to $41.6 million in the second quarter of 2017 and $27.8 million in the third quarter of 2016. Noninterest income in the third quarter of 2017 decreased compared to the second quarter of 2017, primarily due to decreases in net gain on sale of loans and other mortgage banking revenue of $4.6 million and other charges and fees for customer services of $3.1 million. The decrease in net gain on sale of loans and other mortgage banking revenue, included a $4.0 million detriment to earnings due to a change in fair value in loan servicing rights in the third quarter of 2017, compared to a $1.8 million detriment in the second quarter of 2017. The decrease in other charges and fees for customers services in the third quarter of 2017, compared to the second quarter of 2017, was primarily due to a reduction in interchange fees resulting from limitations set by the Durbin amendment, which became effective for the Corporation July 1, 2017.
Operating expenses were $119.5 million in the third quarter of 2017, compared to $98.2 million in the second quarter of 2017 and $106.1 million in the third quarter of 2016. Operating expenses included merger and restructuring expenses of $21.2 million in the third quarter of 2017, $0.5 million in the second quarter of 2017 and $37.5 million

2


in the third quarter of 2016. The increase in merger and restructuring expenses in the third quarter of 2017, compared to the second quarter of 2017, was primarily due to the Corporation's previously announced restructuring efforts. Third quarter of 2017 other operating expenses included $3.1 million of impairment related to a federal housing tax credit placed into service in the third quarter of 2017. Excluding merger and restructuring expenses and the impairment of federal housing tax credit, core operating expenses were $95.2 million in the third quarter of 2017, a decrease of $2.5 million compared to the second quarter of 2017.(4) We expect a decline in operating expenses from the previously announced restructuring efforts to be evident in the fourth quarter of 2017.
The Corporation's effective tax rate was 20.2% in the third quarter of 2017, compared to 30.7% in the second quarter of 2017 and 19.9% in the third quarter of 2016. The tax rate for the third quarter of 2017 benefited from a federal housing tax credit placed into service during the quarter. The income tax benefit from the tax credit placed into service was partially offset by the impairment recorded on the same tax credit included within other operating expenses. The tax rate for the third quarter of 2016 benefited from stock option exercises that occurred in the third quarter of 2016.
The efficiency ratio is a measure of operating expenses as a percentage of net interest income and noninterest income. The Corporation's efficiency ratio was 68.0% in the third quarter of 2017, compared to 54.7% in the second quarter of 2017 and 85.2% in the third quarter of 2016. The Corporation's adjusted efficiency ratio, which excludes significant items, amortization of intangibles, impairment of income tax credits, the net interest income FTE adjustment and gains from sale of investment securities and closed branch locations, was 51.2% in the third quarter of 2017, compared to 52.2% in the second quarter of 2017 and 52.7% in the third quarter of 2016.(5)  
Total assets were $19.35 billion at September 30, 2017, compared to $18.78 billion at June 30, 2017 and $17.38 billion at September 30, 2016. The increase in total assets during the three months ended September 30, 2017 was primarily attributable to an increase in investment securities and loan growth that was funded primarily by an increase in deposits. During the quarter, the investment securities portfolio grew by $273.8 million to $2.69 billion at September 30, 2017. The increase in total assets during the twelve months ended September 30, 2017 was primarily attributable to organic loan growth and an increase in investment securities.
Total loans were $13.83 billion at September 30, 2017, an increase of $166.0 million, or 1.2%, from total loans of $13.67 billion at June 30, 2017 and an increase of $1.12 billion, or 8.8%, from total loans of $12.72 billion at September 30, 2016. The Corporation experienced organic loan growth of $166.0 million during the third quarter of 2017 and $1.12 billion during the twelve months ended September 30, 2017.
Total deposits were $13.81 billion at September 30, 2017, compared to $13.20 billion at June 30, 2017 and $13.27 billion at September 30, 2016. The increase in deposits during the three months ended September 30, 2017 was primarily due to an increase in interest-bearing demand accounts and other time deposits. The Corporation experienced organic growth in customer deposits of $591.8 million during the third quarter of 2017.
Securities sold under agreements to repurchase with customers were $414.6 million at September 30, 2017, compared to $310.0 million at June 30, 2017 and $326.8 million at September 30, 2016. Short-term borrowings were $1.90 billion at September 30, 2017, compared to $2.05 billion at June 30, 2017 and $400.0 million at September 30, 2016 and consisted of short-term FHLB advances utilized by the Corporation to fund short-term liquidity needs. Long-term borrowings were $397.8 million at September 30, 2017, compared to $435.9 million at June 30, 2017 and $676.6 million at September 30, 2016.
The Corporation's shareholders' equity to total assets ratio was 13.8% at September 30, 2017, compared to 14.1% at June 30, 2017 and 14.7% at September 30, 2016. The Corporation's tangible equity to tangible assets ratio and total risk-based capital ratio were 8.3% and 11.2% (estimated), respectively, at September 30, 2017 compared to 8.4% and 11.1%, respectively, at June 30, 2017 and 8.7% and 11.1%, respectively, at September 30, 2016. (6) The Corporation's book value was $37.57 per share at September 30, 2017, compared to $37.11 per share at June 30, 2017 and $36.37 per share at September 30, 2016. The Corporation's tangible book value was $21.36 per share at September 30, 2017, compared to $20.89 per share at June 30, 2017 and $19.99 per share at September 30, 2016.(7) 
(1) Net income, excluding significant items, and diluted earnings per share, excluding significant items, are non-GAAP financial measures. Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables

3


entitled "Reconciliation of Non-GAAP Financial Measures" for a reconciliation to the most directly comparable GAAP financial measures. For the fourth quarter of 2016, "significant items" also includes gain on sales of branch offices.
(2) Return on average assets, excluding significant items, return on average shareholders’ equity, excluding significant items, and return on average tangible shareholders' equity, excluding significant items, are non-GAAP financial measures. Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables entitled "Reconciliation of Non-GAAP Financial Measures" for a reconciliation to the most directly comparable GAAP financial measures.
(3) Net interest margin, on a tax equivalent basis, is a non-GAAP financial measure. Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables entitled "Average Balances, Fully Tax Equivalent (FTE) Interest and Effective Yields and Rates" for a reconciliation of net interest income used to compute net interest margin on a tax equivalent basis to the most directly comparable GAAP financial measure.
(4) Core operating expenses, excluding merger and restructuring expenses and impairment of federal housing tax credits is a non-GAAP financial measure. Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables entitled "Reconciliation of Non-GAAP Financial Measures" for a reconciliation to the most directly comparable GAAP financial measures.
(5) Adjusted efficiency ratio is a non-GAAP financial measure, which excludes significant items, amortization of intangibles, impairment of income tax credits, net interest income FTE adjustment, gains from sale of investment securities and closed branch locations. Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables entitled "Reconciliation of Non-GAAP Financial Measures" for a reconciliation to the most directly comparable GAAP financial measure.
(6) Tangible equity to tangible assets ratio is a non-GAAP financial measure. Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables entitled "Reconciliation of Non-GAAP Financial Measures" for a reconciliation to the most directly comparable GAAP financial measure.
(7) Tangible book value per share is a non-GAAP financial measure. Please refer to the section entitled "Non-GAAP Financial Measures" in this press release and to the financial tables entitled "Reconciliation of Non-GAAP Financial Measures" for a reconciliation to the most directly comparable GAAP financial measure.
Conference Call Details
Chemical Financial Corporation will host a conference call to discuss its third quarter 2017 operating results on Wednesday, October 25, 2017, at 10:30 a.m. ET. Anyone interested may access the conference call on a live basis by dialing toll-free at 1-844-616-0064 and entering 658387 for the conference ID. The call will also be broadcast live over the Internet hosted at Chemical Financial Corporation's website at www.chemicalbank.com under the "Investor Info" section. A copy of the slide-show presentation and an audio replay of the call will remain available on Chemical Financial Corporation's website for at least 14 days.
About Chemical Financial Corporation
Chemical Financial Corporation is the largest banking company headquartered and operating branch offices in Michigan. The Corporation operates through its subsidiary bank, Chemical Bank, with 236 banking offices located primarily in Michigan, northeast Ohio and northern Indiana. At September 30, 2017, the Corporation had total assets of $19.35 billion. Chemical Financial Corporation's common stock trades on The NASDAQ Stock Market under the symbol CHFC and is one of the issuers comprising The NASDAQ Global Select Market and the S&P MidCap 400 Index. More information about the Corporation is available by visiting the investor relations section of its website at www.chemicalbank.com.
Non-GAAP Financial Measures
This press release contains references to financial measures which are not defined in generally accepted accounting principles ("GAAP"). Such non-GAAP financial measures include the Corporation's tangible equity to tangible assets ratio, tangible book value per share, presentation of net interest income and net interest margin on a fully taxable equivalent (FTE) basis, operating expenses-core (which excludes merger and restructuring expenses and impairment of income tax credits), operating expenses-efficiency ratio (which excludes merger and restructuring expenses, impairment of income tax credits and amortization of intangibles), the adjusted efficiency ratio (which excludes significant items, impairment of income tax credits, amortization of intangibles, net interest income FTE adjustments, gains from sale of investment securities and closed branch locations) and other information presented

4


excluding significant items, including net income, diluted earnings per share, return on average assets and return on average shareholders' equity.
These non-GAAP financial measures have been included as the Corporation believes they are helpful for investors to analyze and evaluate the Corporation's financial condition. However, these non-GAAP financial measures have inherent limitations and should not be considered in isolation or as a substitute for GAAP measures. In addition, because non-GAAP measures are not standardized, it may not be possible to compare the non-GAAP historical measures in this press release with other companies non-GAAP financial measures. Reconciliations of non-GAAP financial measures to the most directly comparable GAAP financial measure may be found in the financial tables included with this press release.
Forward-Looking Statements
This press release contains forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates and projections about the financial services industry, the economy and the Corporation. Words and phrases such as "anticipates," "believes," "continue," "estimates," "expects," "forecasts," "future," "intends," "is likely," "judgment," "look ahead," "look forward," "on schedule," "opinion," "opportunity," "plans," "potential," "predicts," "probable," "projects," "should," "strategic," "trend," "will," and variations of such words and phrases or similar expressions are intended to identify such forward-looking statements. These statements include, among others, statements related to our belief that we are on target to achieve the long-term growth prospects established as part of our most recent merger performance targets and our expectations regarding operating expenses related to our restructuring efforts. . All statements referencing future time periods are forward-looking.
Management's determination of the provision and allowance for loan losses; the carrying value of acquired loans, goodwill and mortgage servicing rights; the fair value of investment securities (including whether any impairment on any investment security is temporary or other-than-temporary and the amount of any impairment); and management's assumptions concerning pension and other postretirement benefit plans involve judgments that are inherently forward-looking. There can be no assurance that future loan losses will be limited to the amounts estimated. All of the information concerning interest rate sensitivity is forward-looking. The future effect of changes in the financial and credit markets and the national and regional economies on the banking industry, generally, and on the Corporation, specifically, are also inherently uncertain.
Forward-looking statements are based upon current beliefs and expectations and involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Accordingly, such statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions ("risk factors") that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements. The Corporation undertakes no obligation to update, amend or clarify forward-looking statements, whether as a result of new information, future events or otherwise. Risk factors include, without limitation, a downturn in the economy, particularly in our markets, volatile credit and financial markets both domestic and foreign, potential deterioration in real estate value, regulatory changes, excessive loan losses, the Corporation's inability to attract and retain new commercial lenders and other bankers as well as key operations staff in light of competition for experienced employees in the banking industry, the Corporation's inability to grow its deposits while reducing the number of physical branches that is operates, and negative reactions to the restructuring efforts by Chemical Bank's customers, employees and other counterparties.
In addition, risk factors include, but are not limited to, the risk factors described in Item 1A of the Corporation's Annual Report on Form 10-K for the year ended December 31, 2016. These and other factors are representative of the risk factors that may emerge and could cause a difference between an ultimate actual outcome and a preceding forward-looking statement.

5


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Consolidated Statements of Financial Position (Unaudited)
Chemical Financial Corporation
(In thousands, except per share data)
 
September 30,
2017
 
June 30,
2017
 
December 31,
2016
 
September 30,
2016
 
 
 
 
 
 
 
 
Assets
 
 
 
 
 
 
 
Cash and cash equivalents:
 
 
 
 
 
 
 
Cash and cash due from banks
$
223,498

 
$
230,219

 
$
237,758

 
$
286,351

Interest-bearing deposits with the Federal Reserve Bank and other banks and federal funds sold
485,713

 
389,022

 
236,644

 
270,216

Total cash and cash equivalents
709,211

 
619,241

 
474,402

 
556,567

Investment securities:
 
 
 
 
 
 
 
Available-for-sale
2,029,672

 
1,767,478

 
1,234,964

 
1,303,381

Held-to-maturity
657,176

 
645,605

 
623,427

 
563,721

Total investment securities
2,686,848

 
2,413,083

 
1,858,391

 
1,867,102

Loans held-for-sale
87,198

 
65,371

 
81,830

 
276,061

Loans:
 
 
 
 
 
 
 
Total loans
13,833,368

 
13,667,372

 
12,990,779

 
12,715,789

Allowance for loan losses
(85,760
)
 
(83,797
)
 
(78,268
)
 
(73,775
)
Net loans
13,747,608

 
13,583,575

 
12,912,511

 
12,642,014

Premises and equipment
141,550

 
146,460

 
145,012

 
144,165

Loan servicing rights
62,195

 
64,522

 
58,315

 
51,393

Goodwill
1,134,568

 
1,133,534

 
1,133,534

 
1,137,166

Other intangible assets
35,797

 
37,322

 
40,211

 
35,700

Interest receivable and other assets
749,333

 
718,297

 
650,973

 
673,469

Total Assets
$
19,354,308

 
$
18,781,405

 
$
17,355,179

 
$
17,383,637

Liabilities
 
 
 
 
 
 
 
Deposits:
 
 
 
 
 
 
 
Noninterest-bearing
$
3,688,848

 
$
3,626,592

 
$
3,341,520

 
$
3,264,934

Interest-bearing
10,116,397

 
9,577,775

 
9,531,602

 
10,007,928

Total deposits
13,805,245

 
13,204,367

 
12,873,122

 
13,272,862

Interest payable and other liabilities
163,532

 
141,702

 
134,637

 
143,708

Securities sold under agreements to repurchase with customers
414,597

 
310,042

 
343,047

 
326,789

Short-term borrowings
1,900,000

 
2,050,000

 
825,000

 
400,000

Long-term borrowings
397,845

 
435,852

 
597,847

 
676,612

Total liabilities
16,681,219

 
16,141,963

 
14,773,653

 
14,819,971

Shareholders' Equity
 
 
 
 
 
 
 
Preferred stock, no par value per share

 

 

 

Common stock, $1 par value per share
71,152

 
71,131

 
70,599

 
70,497

Additional paid-in capital
2,201,334

 
2,197,501

 
2,210,762

 
2,206,182

Retained earnings
425,433

 
404,939

 
340,201

 
312,129

Accumulated other comprehensive loss
(24,830
)
 
(34,129
)
 
(40,036
)
 
(25,142
)
Total shareholders' equity
2,673,089

 
2,639,442

 
2,581,526

 
2,563,666

Total Liabilities and Shareholders' Equity
$
19,354,308

 
$
18,781,405

 
$
17,355,179

 
$
17,383,637



6


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Consolidated Statements of Income (Unaudited)
Chemical Financial Corporation
(In thousands, except per share data)
 
Three Months Ended
 
Nine Months Ended
 
September 30,
2017
 
June 30,
2017
 
September 30,
2016
 
September 30,
2017
 
September 30,
2016
Interest Income
 
 
 
 
 
 
 
 
 
Interest and fees on loans
$
148,771

 
$
141,314

 
$
97,103

 
$
422,570

 
$
249,082

Interest on investment securities:
 
 
 
 
 
 
 
 
 
Taxable
9,326

 
7,125

 
2,575

 
21,207

 
6,302

Tax-exempt
4,577

 
4,426

 
3,072

 
13,238

 
8,377

Dividends on nonmarketable equity securities
1,039

 
1,246

 
358

 
2,906

 
1,391

Interest on deposits with the Federal Reserve Bank and other banks and federal funds sold
1,231

 
1,022

 
454

 
3,052

 
811

Total interest income
164,944

 
155,133

 
103,562

 
462,973

 
265,963

Interest Expense
 
 
 
 
 
 
 
 
 
Interest on deposits
12,926

 
10,582

 
5,836

 
32,424

 
14,155

Interest on short-term borrowings
6,591

 
4,659

 
459

 
12,908

 
785

Interest on long-term borrowings
1,799

 
1,944

 
458

 
5,968

 
2,389

Total interest expense
21,316

 
17,185

 
6,753

 
51,300

 
17,329

Net Interest Income
143,628

 
137,948

 
96,809

 
411,673

 
248,634

Provision for loan losses
5,499

 
6,229

 
4,103

 
15,778

 
8,603

Net interest income after provision for loan losses
138,129

 
131,719

 
92,706

 
395,895

 
240,031

Noninterest Income
 
 
 
 
 
 
 
 
 
Service charges and fees on deposit accounts
9,147

 
8,777

 
7,665

 
25,928

 
19,722

Wealth management revenue
6,188

 
6,958

 
5,584

 
18,973

 
16,567

Other charges and fees for customer services
6,624

 
9,734

 
7,410

 
25,249

 
20,265

Net gain on sale of loans and other mortgage banking revenue
5,241

 
9,879

 
4,439

 
24,280

 
7,439

Gain on sale of investment securities
1

 
77

 
16

 
168

 
53

Other
4,921

 
6,143

 
2,656

 
17,102

 
4,040

Total noninterest income
32,122

 
41,568

 
27,770

 
111,700

 
68,086

Operating Expenses
 
 
 
 
 
 
 
 
 
Salaries, wages and employee benefits
52,621

 
52,601

 
40,565

 
165,470

 
107,582

Occupancy
6,871

 
8,745

 
5,462

 
23,008

 
15,881

Equipment and software
7,582

 
8,149

 
6,420

 
24,248

 
15,699

Outside processing and service fees
9,626

 
8,924

 
5,365

 
26,061

 
13,909

Merger expenses
2,379

 
465

 
37,470

 
7,011

 
43,118

Restructuring expenses
18,824

 

 

 
18,824

 

Other
21,636

 
19,353

 
10,862

 
57,350

 
27,927

Total operating expenses
119,539

 
98,237

 
106,144

 
321,972

 
224,116

Income before income taxes
50,712

 
75,050

 
14,332

 
185,623

 
84,001

Income tax expense
10,253

 
23,036

 
2,848

 
45,546

 
23,137

Net Income
$
40,459

 
$
52,014

 
$
11,484

 
$
140,077

 
$
60,864

Earnings Per Common Share:
 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding-basic
70,911

 
70,819

 
49,107

 
70,787

 
41,881

Weighted average common shares outstanding-diluted
71,505

 
71,443

 
49,631

 
71,454

 
42,321

Basic earnings per share
$
0.57

 
$
0.73

 
$
0.23

 
$
1.98

 
$
1.45

Diluted earnings per share
0.56

 
0.73

 
0.23

 
1.95

 
1.42

Cash Dividends Declared Per Common Share
0.28

 
0.27

 
0.27

 
0.82

 
0.79

Key Ratios (annualized where applicable):
 

 
 
 
 

 
 
 
 
Return on average assets
0.86
%
 
1.14
%
 
0.37
%
 
1.03
%
 
0.79
%
Return on average shareholders' equity
6.1
%
 
8.0
%
 
2.9
%
 
7.2
%
 
6.7
%
Net interest margin (tax-equivalent basis) (non-GAAP)
3.48
%
 
3.48
%
 
3.58
%
 
3.48
%
 
3.62
%
Efficiency ratio - GAAP
68.0
%
 
54.7
%
 
85.2
%
 
61.5
%
 
70.8
%
Efficiency ratio - adjusted (non-GAAP)
51.2
%
 
52.2
%
 
52.7
%
 
53.5
%
 
54.7
%

7


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Selected Quarterly Information (Unaudited)
Chemical Financial Corporation
(Dollars in thousands, except per share data)
 
3rd Quarter 2017
 
2nd Quarter 2017
 
1st Quarter 2017
 
4th Quarter 2016
 
3rd Quarter 2016
 
2nd Quarter 2016
 
1st Quarter 2016
 
 
 
 
Summary of Operations
 
 
 
 
 
 
 
 
 
 
 

 
 

Interest income
$
164,944

 
$
155,133

 
$
142,896

 
$
144,416

 
$
103,562

 
$
82,937

 
$
79,464

Interest expense
21,316

 
17,185

 
12,799

 
11,969

 
6,753

 
5,442

 
5,134

Net interest income
143,628

 
137,948

 
130,097

 
132,447

 
96,809

 
77,495

 
74,330

Provision for loan losses
5,499

 
6,229

 
4,050

 
6,272

 
4,103

 
3,000

 
1,500

Net interest income after provision for loan losses
138,129

 
131,719

 
126,047

 
126,175

 
92,706

 
74,495

 
72,830

Noninterest income
32,122

 
41,568

 
38,010

 
54,264

 
27,770

 
20,897

 
19,419

Operating expenses, excluding merger and restructuring expenses and impairment of income tax credits (non-GAAP)
95,241

 
97,772

 
100,029

 
94,443

 
68,674

 
56,031

 
56,293

Merger and restructuring expenses
21,203

 
465

 
4,167

 
18,016

 
37,470

 
3,054

 
2,594

Impairment of income tax credits
3,095

 

 

 

 

 

 

Income before income taxes
50,712

 
75,050

 
59,861

 
67,980

 
14,332

 
36,307

 
33,362

Income tax expense
10,253

 
23,036

 
12,257

 
18,969

 
2,848

 
10,532

 
9,757

Net income
$
40,459

 
$
52,014

 
$
47,604

 
$
49,011

 
$
11,484

 
$
25,775

 
$
23,605

Significant items, net of tax
16,409

 
1,474

 
3,046

 
2,781

 
25,921

 
1,985

 
1,686

Net income, excluding significant items
$
56,868

 
$
53,488

 
$
50,650

 
$
51,792

 
$
37,405

 
$
27,760

 
$
25,291

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per Common Share Data
 
 
 
 
 
 
 
 
 
 
 

 
 

Net income:
 
 
 
 
 
 
 
 
 
 
 

 
 

Basic
$
0.57

 
$
0.73

 
$
0.67

 
$
0.67

 
$
0.23

 
$
0.67

 
$
0.61

Diluted
0.56

 
0.73

 
0.67

 
0.66

 
0.23

 
0.67

 
0.60

Diluted, excluding significant items (non-GAAP)
0.79

 
0.75

 
0.71

 
0.70

 
0.75

 
0.72

 
0.65

Cash dividends declared
0.28

 
0.27

 
0.27

 
0.27

 
0.27

 
0.26

 
0.26

Book value - period-end
37.57

 
37.11

 
36.56

 
36.57

 
36.37

 
27.45

 
26.99

Tangible book value - period-end
21.36

 
20.89

 
20.32

 
20.20

 
19.99

 
19.68

 
19.20

Market value - period-end
52.26

 
48.41

 
51.15

 
54.17

 
44.13

 
37.29

 
35.69

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key Ratios (annualized where applicable)
 
 
 
 
 
 
 
 
 
 

 
 

Net interest margin (taxable equivalent basis) (non-GAAP)
3.48
%
 
3.48
%
 
3.49
%
 
3.56
%
 
3.58
%
 
3.70
%
 
3.60
%
Efficiency ratio - adjusted
(non-GAAP)
51.2
%
 
52.2
%
 
57.4
%
 
53.7
%
 
52.7
%
 
54.6
%
 
57.6
%
Return on average assets
0.86
%
 
1.14
%
 
1.09
%
 
1.09
%
 
0.37
%
 
1.10
%
 
1.02
%
Return on average shareholders' equity
6.1
%
 
8.0
%
 
7.4
%
 
7.4
%
 
2.9
%
 
10.0
%
 
9.3
%
Average shareholders' equity as a percent of average assets
14.0
%
 
14.3
%
 
14.8
%
 
14.9
%
 
12.7
%
 
11.1
%
 
11.0
%
Capital ratios (period end):
 
 
 
 
 
 
 
 
 
 
 
 
 
Tangible shareholders' equity as a percent of tangible assets
8.3
%
 
8.4
%
 
8.8
%
 
8.8
%
 
8.7
%
 
8.2
%
 
8.2
%
Total risk-based capital ratio (1)
11.2
%
 
11.1
%
 
11.4
%
 
11.5
%
 
11.1
%
 
11.4
%
 
11.5
%
(1) Estimated at September 30, 2017.

8


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Average Balances, Fully Tax Equivalent (FTE) Interest and Effective Yields and Rates(1) (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
 
Three Months Ended
 
September 30, 2017
 
June 30, 2017
 
September 30, 2016
 
Average
Balance
 
Interest (FTE)
 
Effective
Yield/Rate (1)
 
Average
Balance
 
Interest (FTE)
 
Effective
Yield/Rate
 (1)
 
Average
Balance
 
Interest (FTE)
 
Effective
Yield/Rate
 (1)
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest-earning assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loans (1)(2)
$
13,795,750

 
$
149,595

 
4.31
%
 
$
13,513,927

 
$
142,128

 
4.22
%
 
$
9,470,650

 
$
97,880

 
4.12
%
Taxable investment securities
1,629,344

 
9,326

 
2.29

 
1,364,358

 
7,125

 
2.09

 
687,259

 
2,575

 
1.50

Tax-exempt investment securities(1)
896,854

 
7,013

 
3.13

 
882,445

 
6,781

 
3.07

 
592,747

 
4,721

 
3.19

Other interest-earning assets
180,188

 
1,039

 
2.29

 
166,244

 
1,246

 
3.01

 
57,756

 
358

 
2.47

Interest-bearing deposits with the FRB and other banks and federal funds sold
313,104

 
1,231

 
1.56

 
302,022

 
1,022

 
1.36

 
249,731

 
454

 
0.72

Total interest-earning assets
16,815,240

 
168,204

 
3.98

 
16,228,996

 
158,302

 
3.91

 
11,058,143

 
105,988

 
3.82

Less: allowance for loan losses
(84,640
)
 
 
 
 
 
(80,690
)
 
 
 
 
 
(72,242
)
 
 
 
 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash due from banks
250,743

 
 
 
 
 
222,954

 
 
 
 
 
194,171

 
 
 
 
Premises and equipment
146,266

 
 
 
 
 
145,320

 
 
 
 
 
116,944

 
 
 
 
Interest receivable and other assets
1,730,539

 
 
 
 
 
1,748,119

 
 
 
 
 
953,714

 
 
 
 
Total assets
$
18,858,148

 
 
 
 
 
$
18,264,699

 
 
 
 
 
$
12,250,730

 
 
 
 
Liabilities and shareholders' equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest-bearing liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest-bearing demand deposits
$
2,725,807

 
$
1,321

 
0.19
%
 
$
2,682,652

 
$
1,289

 
0.19
%
 
$
2,327,762

 
$
961

 
0.16
%
Savings deposits
4,012,299

 
3,985

 
0.39

 
3,881,260

 
3,047

 
0.31

 
2,512,620

 
749

 
0.12

Time deposits
3,007,109

 
7,620

 
1.01

 
2,958,436

 
6,246

 
0.85

 
2,186,781

 
4,126

 
0.75

Short-term borrowings
2,279,998

 
6,591

 
1.15

 
2,027,505

 
4,659

 
0.92

 
593,903

 
459

 
0.31

Long-term borrowings
426,155

 
1,799

 
1.67

 
474,086

 
1,944

 
1.65

 
494,810

 
458

 
0.37

Total interest-bearing liabilities
12,451,368

 
21,316

 
0.68

 
12,023,939

 
17,185

 
0.57

 
8,115,876

 
6,753

 
0.33

Noninterest-bearing deposits
3,643,765

 

 

 
3,499,686

 

 

 
2,456,469

 

 

Total deposits and borrowed funds
16,095,133

 
21,316

 
0.53

 
15,523,625

 
17,185

 
0.44

 
10,572,345

 
6,753

 
0.25

Interest payable and other liabilities
119,782

 
 
 
 
 
134,557

 
 
 
 
 
118,717

 
 
 
 
Shareholders' equity
2,643,233

 
 
 
 
 
2,606,517

 
 
 
 
 
1,559,668

 
 
 
 
Total liabilities and shareholders' equity
$
18,858,148

 
 
 
 
 
$
18,264,699

 
 
 
 
 
$
12,250,730

 
 
 
 
Net Interest Spread (Average yield earned on interest-earning assets minus average rate paid on interest-bearing liabilities)
 
 
3.30
%
 
 
 
 
 
3.34
%
 
 
 
 
 
3.49
%
Net Interest Income (FTE)
 
 
$
146,888

 
 
 
 
 
$
141,117

 
 
 
 
 
$
99,235

 
 
Net Interest Margin (Net Interest Income (FTE) divided by total average interest-earning assets)
 
 
3.48
%
 
 
 
 
 
3.48
%
 
 
 
 
 
3.58
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation to Reported Net Interest Income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income, fully taxable equivalent (non-GAAP)
 
$
146,888

 
 
 
 
 
$
141,117

 
 
 
 
 
$
99,235

 
 
Adjustments for taxable equivalent interest (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loans
 
 
(824
)
 
 
 
 
 
(814
)
 
 
 
 
 
(777
)
 
 
Tax-exempt investment securities
 
 
(2,436
)
 
 
 
 
 
(2,355
)
 
 
 
 
 
(1,649
)
 
 
Total taxable equivalent interest adjustments
 
(3,260
)
 
 
 
 
 
(3,169
)
 
 
 
 
 
(2,426
)
 
 
Net interest income (GAAP)
 
 
$
143,628

 
 
 
 
 
$
137,948

 
 
 
 
 
$
96,809

 
 
Net interest margin (GAAP)
 
 
3.40%
 
 
 
 
 
3.41
%
 
 
 
 
 
3.49
%
 
 
(1) Fully taxable equivalent (FTE) basis using a federal income tax rate of 35%. The presentation of net interest income on a FTE basis is not in accordance with GAAP, but is customary in the banking industry.
(2) Nonaccrual loans and loans held-for-sale are included in average balances reported and are included in the calculation of yields. Also, tax equivalent interest includes net loan fees.

9


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Average Balances, Fully Tax Equivalent (FTE) Interest and Effective Yields and Rates (1) (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
 
 
Nine Months Ended
 
 
September 30, 2017
 
September 30, 2016
 
 
Average
Balance
 
Interest (FTE)
 
Effective
Yield/Rate (1)
 
Average
Balance
 
Interest (FTE)
 
Effective
Yield/Rate (1)
Assets
 
 
Interest-earning assets:
 
 
 
 
 
 
 
 
 
 
 
 
Loans (1)(2)
 
$
13,490,851

 
$
425,016

 
4.21
%
 
$
8,098,796

 
$
251,274

 
4.14
%
Taxable investment securities
 
1,335,349

 
21,207

 
2.12

 
586,066

 
6,302

 
1.43

Tax-exempt investment securities (1)
 
880,398

 
20,290

 
3.07

 
524,690

 
12,882

 
3.27

Other interest-earning assets
 
150,203

 
2,906

 
2.59

 
46,994

 
1,391

 
3.95

Interest-bearing deposits with the FRB and other banks and federal funds sold
 
294,967

 
3,052

 
1.38

 
156,640

 
811

 
0.69

Total interest-earning assets
 
16,151,768

 
472,471

 
3.91

 
9,413,186

 
272,660

 
3.87

Less: allowance for loan losses
 
(81,337
)
 
 
 
 
 
(72,525
)
 
 
 
 
Other assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash due from banks
 
234,379

 
 
 
 
 
166,927

 
 
 
 
Premises and equipment
 
145,877

 
 
 
 
 
109,159

 
 
 
 
Interest receivable and other assets
 
1,753,337

 
 
 
 
 
665,185

 
 
 
 
Total assets
 
$
18,204,024

 
 
 
 
 
$
10,281,932

 
 
 
 
Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
 
 
 
 
 
Interest-bearing liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Interest-bearing demand deposits
 
$
2,768,209

 
$
3,628

 
0.18
%
 
$
2,058,951

 
$
2,011

 
0.13
%
Savings deposits
 
3,912,672

 
8,753

 
0.30

 
2,212,732

 
1,614

 
0.10

Time deposits
 
2,973,070

 
20,043

 
0.90

 
1,799,691

 
10,530

 
0.78

Short-term borrowings
 
1,848,325

 
12,908

 
0.93

 
454,456

 
785

 
0.23

Long-term borrowings
 
479,344

 
5,968

 
1.66

 
347,925

 
2,389

 
0.92

Total interest-bearing liabilities
 
11,981,620

 
51,300

 
0.57

 
6,873,755

 
17,329

 
0.34

Noninterest-bearing deposits
 
3,484,125

 

 

 
2,115,511

 

 

Total deposits and borrowed funds
 
15,465,745

 
51,300

 
0.44

 
8,989,266

 
17,329

 
0.26

Interest payable and other liabilities
 
126,649

 
 
 
 
 
87,829

 
 
 
 
Shareholders' equity
 
2,611,630

 
 
 
 
 
1,204,837

 
 
 
 
Total liabilities and shareholders' equity
 
$
18,204,024

 
 
 
 
 
$
10,281,932

 
 
 
 
Net Interest Spread (Average yield earned on interest-earning assets minus average rate paid on interest-bearing liabilities)
 
 
 
 
 
3.34
%
 
 
 
 
 
3.53
%
Net Interest Income (FTE)
 
 
 
$
421,171

 
 
 
 
 
$
255,331

 
 
Net Interest Margin (Net Interest Income (FTE) divided by total average interest-earning assets)
 
 
 
 
 
3.48
%
 
 
 
 
 
3.62
%
 
 
 
 
 
 
 
 
 
 
 
 
 
Reconciliation to Reported Net Interest Income
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income, fully taxable equivalent (non-GAAP)
 
 
 
$
421,171

 
 
 
 
 
$
255,331

 
 
Adjustments for taxable equivalent interest (1):
 
 
 
 
 
 
 
 
 
 
 
 
Loans
 
 
 
(2,446
)
 
 
 
 
 
(2,192
)
 
 
Tax-exempt investment securities
 
 
 
(7,052
)
 
 
 
 
 
(4,505
)
 
 
Total taxable equivalent interest adjustments
 
 
 
(9,498
)
 
 
 
 
 
(6,697
)
 
 
Net interest income (GAAP)
 
 
 
$
411,673

 
 
 
 
 
$
248,634

 
 
Net interest margin (GAAP)
 
 
 
3.40
%
 
 
 
 
 
3.53
%
 
 
(1) Fully taxable equivalent (FTE) basis using a federal income tax rate of 35%. The presentation of net interest income on a FTE basis is not in accordance with GAAP, but is customary in the banking industry.
(2) Nonaccrual loans and loans held-for-sale are included in average balances reported and are included in the calculation of yields. Also, tax equivalent interest includes net loan fees.

10


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Noninterest Income and Operating Expenses Information (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
 
3rd Quarter 2017
 
2nd Quarter 2017
 
1st Quarter 2017
 
4th Quarter 2016
 
3rd Quarter 2016
 
2nd Quarter 2016
 
1st Quarter 2016
 
 
 
 
Noninterest income
 
 
 
 
 
 
 
 
 
 
 
 
 
Service charges and fees on deposit accounts
$
9,147

 
$
8,777

 
$
8,004

 
$
8,414

 
$
7,665

 
$
6,337

 
$
5,720

Wealth management revenue
6,188

 
6,958

 
5,827

 
6,034

 
5,584

 
5,782

 
5,201

Electronic banking fees
4,370

 
7,482

 
6,817

 
8,196

 
5,533

 
4,786

 
4,918

Net gain on sale of loans and other mortgage banking revenue
5,241

 
9,879

 
9,160

 
14,420

 
4,439

 
1,595

 
1,405

Other fees for customer services
2,254

 
2,252

 
2,074

 
1,785

 
1,877

 
1,677

 
1,474

Gain on sale of investment securities
1

 
77

 
90

 
76

 
16

 
18

 
19

Gain on sale of branch offices

 

 

 
7,391

 

 

 

Other
4,921

 
6,143

 
6,038

 
7,948

 
2,656

 
702

 
682

Total noninterest income
$
32,122

 
$
41,568

 
$
38,010

 
$
54,264

 
$
27,770

 
$
20,897

 
$
19,419


 
3rd Quarter 2017
 
2nd Quarter 2017
 
1st Quarter 2017
 
4th Quarter 2016
 
3rd Quarter 2016
 
2nd Quarter 2016
 
1st Quarter 2016
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and wages
$
44,641

 
$
44,959

 
$
48,526

 
$
47,936

 
$
33,841

 
$
26,887

 
$
26,743

Employee benefits
7,980

 
7,642

 
11,722

 
9,695

 
6,724

 
6,240

 
7,147

Occupancy
6,871

 
8,745

 
7,392

 
7,644

 
5,462

 
5,514

 
4,905

Equipment and software
7,582

 
8,149

 
8,517

 
8,709

 
6,420

 
4,875

 
4,404

Outside processing and service fees
9,626

 
8,924

 
7,511

 
7,290

 
5,365

 
4,833

 
3,711

FDIC insurance premiums
2,768

 
2,460

 
1,406

 
2,813

 
1,849

 
1,338

 
1,407

Professional fees
3,489

 
2,567

 
1,968

 
2,304

 
1,472

 
1,020

 
1,036

Intangible asset amortization
1,526

 
1,525

 
1,513

 
1,843

 
1,292

 
1,195

 
1,194

Credit-related expenses
1,874

 
1,895

 
1,200

 
(1,029
)
 
(371
)
 
(1,331
)
 
30

Merger expenses
2,379

 
465

 
4,167

 
18,016

 
37,470

 
3,054

 
2,594

Restructuring expenses
18,824

 

 

 

 

 

 

Impairment of income tax credit
3,095

 

 

 

 

 

 

Other
8,884

 
10,906

 
10,274

 
9,081

 
6,620

 
5,460

 
5,716

Total operating expenses
$
119,539

 
$
98,237

 
$
104,196

 
$
114,302

 
$
106,144

 
$
59,085

 
$
58,887




11


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Composition of Loans and Deposits and Additional Information on Intangible Assets (Unaudited)
Chemical Financial Corporation
(Dollars in Thousands)
 
 
 
 
 
Organic Growth -
 
 
 
 
 
 
 
Organic Growth -
 
Sep 30,
2017
 
June 30, 2017
 
Three Months Ended September 30, 2017
 
March 31,
2017
 
Dec 31,
2016
 
Sep 30,
2016
 
Twelve Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Composition of Loans
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial loan portfolio:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial
$
3,319,965

 
$
3,360,161

 
(1.2
)%
 
$
3,253,608

 
$
3,217,300

 
$
3,199,576

 
3.8
 %
Commercial real estate
4,315,978

 
4,324,323

 
(0.2
)
 
4,097,771

 
3,973,140

 
3,733,377

 
15.6

Real estate construction
501,413

 
446,678

 
12.3

 
453,811

 
403,772

 
500,494

 
0.2

Subtotal - commercial loans
8,137,356

 
8,131,162

 
0.1

 
7,805,190

 
7,594,212

 
7,433,447

 
9.5

Consumer loan portfolio:
 
 
 
 
 
 
 
 
 
 
 
 
 
Residential mortgage
3,221,307

 
3,125,397

 
3.1

 
3,133,465

 
3,086,474

 
3,046,959

 
5.7

Consumer installment
1,615,983

 
1,553,967

 
4.0

 
1,481,057

 
1,433,884

 
1,335,707

 
21.0

Home equity
858,722

 
856,846

 
0.2

 
853,680

 
876,209

 
899,676

 
(4.6
)
Subtotal - consumer loans
5,696,012

 
5,536,210

 
2.9

 
5,468,202

 
5,396,567

 
5,282,342

 
7.8

Total loans
$
13,833,368

 
$
13,667,372

 
1.2
 %
 
$
13,273,392

 
$
12,990,779

 
$
12,715,789

 
8.8
 %

 
 
 
 
 
Organic Growth -
 
 
 
 
 
 
 
Organic Growth -
 
Sep 30,
2017
 
June 30,
2017
 
Three Months Ended September 30, 2017
 
March 31,
2017
 
Dec 31,
2016
 
Sep 30,
2016
 
Twelve Months Ended September 30, 2017
Composition of Deposits
 
 
 
 
 
 
 
 
 
 
 
 
 
Noninterest-bearing demand
$
3,688,848

 
$
3,626,592

 
1.7
 %
 
$
3,399,287

 
$
3,341,520

 
$
3,264,934

 
13.0
 %
Savings
1,736,360

 
1,749,199

 
(0.7
)
 
1,752,040

 
1,662,115

 
1,650,276

 
5.2

Interest-bearing demand
2,976,212

 
2,606,032

 
14.2

 
2,900,546

 
2,825,801

 
3,316,635

 
(10.3
)
Money market accounts
2,289,852

 
2,235,412

 
2.4

 
2,161,645

 
2,033,319

 
1,692,656

 
35.3

Brokered deposits
132,806

 
123,728

 
7.3

 
156,367

 
226,429

 
474,902

 
(72.0
)
Other time deposits
2,981,167

 
2,863,404

 
4.1

 
2,762,462

 
2,783,938

 
2,873,459

 
3.7

Total deposits
$
13,805,245

 
$
13,204,367

 
4.6
 %
 
$
13,132,347

 
$
12,873,122

 
$
13,272,862

 
4.0
 %


 
September 30,
2017
 
June 30,
2017
 
March 31,
2017
 
December 31,
2016
 
September 30,
2016
 
 
 
 
 
 
 
 
 
 
Additional Data - Intangibles
 
 
 
 
 
 
 
 
 
Goodwill
$
1,134,568

 
$
1,133,534

 
$
1,133,534

 
$
1,133,534

 
$
1,137,166

Loan servicing rights
62,195

 
64,522

 
64,604

 
58,315

 
51,393

Core deposit intangibles (CDI)
35,747

 
37,235

 
38,723

 
40,211

 
35,618

Noncompete agreements
50

 
87

 
125

 

 
82



12


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Nonperforming Assets (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
 
Sep 30,
2017
 
June 30, 2017
 
March 31,
2017
 
Dec 31,
2016
 
Sep 30,
2016
 
June 30,
2016
 
March 31,
2016
Nonperforming Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
Nonperforming Loans (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
Nonaccrual loans:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial
$
15,648

 
$
18,773

 
$
16,717

 
$
13,178

 
$
13,742

 
$
14,577

 
$
19,264

Commercial real estate
25,150

 
19,723

 
20,828

 
19,877

 
19,914

 
21,325

 
25,859

Real estate construction
78

 
56

 
79

 
80

 
80

 
496

 
546

Residential mortgage
8,646

 
7,714

 
6,749

 
6,969

 
5,119

 
5,343

 
5,062

Consumer installment
875

 
757

 
755

 
879

 
378

 
285

 
360

Home equity
3,908

 
3,871

 
2,713

 
3,351

 
2,064

 
1,971

 
2,328

Total nonaccrual loans(1)
54,305

 
50,894

 
47,841

 
44,334

 
41,297

 
43,997

 
53,419

Other real estate and repossessed assets
10,605

 
14,582

 
16,395

 
17,187

 
20,730

 
8,440

 
9,248

Total nonperforming assets
$
64,910

 
$
65,476

 
$
64,236

 
$
61,521

 
$
62,027

 
$
52,437

 
$
62,667

Accruing loans contractually past due 90 days or more as to interest or principal payments, excluding acquired loans accounted for under ASC 310-30:
 
 
Commercial
$
3,521

 
$
58

 
$
1,823

 
$
11

 
$
221

 
$
3

 
$
370

Commercial real estate
144

 
262

 
700

 
277

 
739

 
3

 

Real estate construction

 

 

 

 
1,439

 

 

Residential mortgage

 

 

 

 
375

 
407

 
423

Home equity
2,367

 
2,026

 
1,169

 
995

 
628

 
1,071

 
679

Total accruing loans contractually past due 90 days or more as to interest or principal payments
$
6,032

 
2,346

 
$
3,692

 
$
1,283

 
$
3,402

 
$
1,484

 
$
1,472

(1) Acquired loans, accounted for under Accounting Standards Codification 310-30, that are not performing in accordance with contractual terms are not reported as nonperforming loans because these loans are recorded in pools at their net realizable value based on the principal and interest the Corporation expects to collect on these loans.

13


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Summary of Allowance and Loan Loss Experience (Unaudited)
Chemical Financial Corporation
(Dollars in thousands)
 
3rd Quarter 2017
 
2nd Quarter 2017
 
1st Quarter 2017
 
4th Quarter 2016
 
3rd Quarter 2016
 
2nd Quarter 2016
 
1st Quarter 2016
 
Nine Months Ended
 
 
 
 
 
 
 
 
Sep 30,
2017
 
Sep 30,
2016
Allowance for loan losses - originated loan portfolio
 
 
 
 
 
 
 
 
  Allowance for loan losses - beginning of period
$
83,797

 
$
78,774

 
$
78,268

 
$
73,775

 
$
71,506

 
$
70,318

 
$
73,328

 
$
78,268

 
$
73,328

Provision for loan losses
4,921

 
6,229

 
4,050

 
6,272

 
4,103

 
3,000

 
1,500

 
15,200

 
8,603

Net loan (charge-offs) recoveries:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial
(2,348
)
 
(239
)
 
(1,999
)
 
(336
)
 
(150
)
 
(1,153
)
 
(3,115
)
 
(4,586
)
 
(4,418
)
Commercial real estate
(174
)
 
(205
)
 
730

 
(280
)
 
(154
)
 
(187
)
 
(440
)
 
351

 
(781
)
Real estate construction

 

 
(9
)
 
36

 
(31
)
 

 
(11
)
 
(9
)
 
(42
)
Residential mortgage
(44
)
 
19

 
(567
)
 
(236
)
 
(304
)
 
8

 
(172
)
 
(592
)
 
(468
)
Consumer installment
(858
)
 
(747
)
 
(1,310
)
 
(823
)
 
(1,137
)
 
(486
)
 
(602
)
 
(2,915
)
 
(2,225
)
Home equity
(113
)
 
(34
)
 
(389
)
 
(140
)
 
(58
)
 
6

 
(170
)
 
(536
)
 
(222
)
Net loan charge-offs
(3,537
)
 
(1,206
)
 
(3,544
)
 
(1,779
)
 
(1,834
)
 
(1,812
)
 
(4,510
)
 
(8,287
)
 
(8,156
)
Allowance for loan losses - end of period
85,181

 
83,797

 
78,774

 
78,268

 
73,775

 
71,506

 
70,318

 
85,181

 
73,775

Allowance for loan losses - acquired loan portfolio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Allowance for loan losses - beginning of period

 

 

 

 

 

 

 

 

Provision for loan losses
579

 

 

 

 

 

 

 
579

 

Allowance for loan losses - end of period
579

 

 

 

 

 

 

 
579

 

Total allowance for loan losses
$
85,760

 
$
83,797

 
$
78,774

 
$
78,268

 
$
73,775

 
$
71,506

 
$
70,318

 
$
85,760

 
$
73,775

Net loan charge-offs as a percent of average loans (annualized)
0.10
%
 
0.04
%
 
0.11
%
 
0.06
%
 
0.08
%
 
0.10
%
 
0.25
%
 
0.08
%
 
0.13
%

 
Sep 30,
2017
 
June 30,
2017
 
March 31,
2017
 
Dec 31,
2016
 
Sep 30,
2016
Originated loans
$
9,156,096

 
$
8,659,622

 
$
7,959,769

 
$
7,458,401

 
$
6,755,931

Acquired loans
4,677,272

 
5,007,750

 
5,313,623

 
5,532,378

 
5,959,858

Total loans
$
13,833,368

 
$
13,667,372

 
$
13,273,392

 
$
12,990,779

 
$
12,715,789

 
 
 
 
 
 
 
 
 
 
Allowance for loan losses (originated loan portfolio) as a percent of:
Total originated loans
0.93
%
 
0.97
%
 
0.99
%
 
1.05
%
 
1.09
%
Nonperforming loans
156.9
%
 
164.7
%
 
177.7
%
 
176.5
%
 
178.6
%
Credit mark as a percent of unpaid principal balance on acquired loans
2.7
%
 
2.6
%
 
2.8
%
 
3.1
%
 
3.0
%

14


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Reconciliation of Non-GAAP Financial Measures (Unaudited)
Chemical Financial Corporation
(Amounts in thousands)
 
3rd Quarter 2017
 
2nd Quarter 2017
 
1st Quarter 2017
 
4th Quarter 2016
 
3rd Quarter 2016
 
2nd Quarter 2016
 
1st Quarter 2016
 
Nine Months Ended
 
 
 
 
 
 
 
 
Sep 30,
2017
 
Sep 30,
2016
Non-GAAP Operating Results
 
 
 
 
 
 
 
 
 
 
 
 
Net Income
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, as reported
$
40,459

 
$
52,014

 
$
47,604

 
$
47,168

 
$
11,484

 
$
25,775

 
$
23,605

 
$
140,077

 
$
60,864

Merger and restructuring expenses
21,203

 
465

 
4,167

 
18,016

 
37,470

 
3,054

 
2,594

 
25,835

 
43,118

Gain on sales of branch offices

 

 

 
(7,391
)
 

 

 

 

 

Loan servicing rights change in fair valuation
4,041

 
1,802

 
519

 
(6,348
)
 
1,236

 

 

 
6,362

 
1,236

Significant items
25,244

 
2,267

 
4,686

 
4,277

 
38,706

 
3,054

 
2,594

 
32,197

 
44,354

Income tax benefit (1)
(8,835
)
 
(793
)
 
(1,640
)
 
(1,496
)
 
(12,785
)
 
(1,069
)
 
(908
)
 
(11,268
)
 
(14,762
)
Significant items, net of tax
16,409

 
1,474

 
3,046

 
2,781

 
25,921

 
1,985

 
1,686

 
20,929

 
29,592

Net income, excluding significant items
$
56,868

 
$
53,488

 
$
50,650

 
$
49,949

 
$
37,405

 
$
27,760

 
$
25,291

 
$
161,006

 
$
90,456

Diluted Earnings Per Share
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diluted earnings per share, as reported
$
0.56

 
$
0.73

 
$
0.67

 
$
0.66

 
$
0.23

 
$
0.67

 
$
0.60

 
$
1.95

 
$
1.42

Effect of significant items, net of tax
0.23

 
0.02

 
0.04

 
0.04

 
0.52

 
0.05

 
0.05

 
0.29

 
0.69

Diluted earnings per share, excluding significant items
$
0.79

 
$
0.75

 
$
0.71

 
$
0.70

 
$
0.75

 
$
0.72

 
$
0.65

 
$
2.24

 
$
2.11

Return on Average Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Return on average assets, as reported
0.86
%
 
1.14%
 
1.09
%
 
1.09
%
 
0.37
%
 
1.10
%
 
1.02
%
 
1.03
%
 
0.79
%
Effect of significant items, net of tax
0.35

 
0.03
 
0.07

 
0.07

 
0.85

 
0.09

 
0.07

 
0.15

 
0.38

Return on average assets, excluding significant items
1.21
%
 
1.17%
 
1.16
%
 
1.16
%
 
1.22
%
 
1.19
%
 
1.09
%
 
1.18
%
 
1.17
%
Return on Average Shareholders' Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Return on average shareholders' equity, as reported
6.1
%
 
8.0
%
 
7.4
%
 
7.4
%
 
2.9
%
 
10.0
%
 
9.3
%
 
7.2
%
 
6.7
%
Effect of significant items, net of tax
2.5

 
0.2

 
0.4

 
0.4

 
6.7

 
0.7

 
0.6

 
1.0

 
3.3

Return on average shareholders' equity, excluding significant items
8.6
%
 
8.2
%
 
7.8
%
 
7.8
%
 
9.6
%
 
10.7
%
 
9.9
%
 
8.2
%
 
10.0
%
Return on Average Tangible Shareholders' Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average shareholders' equity
$2,643,233
 
$2,606,517
 
$2,584,501
 
$2,564,943
 
$1,559,668
 
$1,033,014
 
$1,017,929
 
$2,611,630
 
$1,204,837
Average goodwill, CDI and noncompete agreements, net of tax
1,153,394
 
1,154,229
 
1,155,177
 
1,153,598
 
585,393
 
295,882
 
299,685
 
1,154,243
 
393,023
Average tangible shareholders' equity
$1,489,839
 
$1,452,288
 
$1,429,324
 
$1,411,345
 
$974,275
 
$737,132
 
$718,244
 
$1,457,387
 
$811,814
Return on average tangible shareholders' equity
10.9
%
 
14.3%
 
13.3
%
 
13.4
%
 
4.7
%
 
14.0
%
 
13.1
%
 
12.8
%
 
10.0
%
Effect of significant items, net of tax
4.4

 
0.4

 
0.9

 
0.8

 
10.7

 
1.1

 
1.0

 
1.9

 
4.9

Return on average tangible shareholders' equity, excluding significant items
15.3
%
 
14.7
%
 
14.2
%
 
14.2
%
 
15.4
%
 
15.1
%
 
14.1
%
 
14.7
%
 
14.9
%
(1) Assumes merger and restructuring expenses and other significant items are deductible at an income tax rate of 35%, except for the impact of estimated nondeductible expenses incurred in periods when the Corporation completed the merger transaction.

15


Chemical Financial Corporation Announces 2017 Third Quarter Operating Results
 
Reconciliation of Non-GAAP Financial Measures (Unaudited)
Chemical Financial Corporation
(Amounts in thousands, except per share data)
 
3rd Quarter 2017
 
2nd Quarter 2017
 
1st Quarter 2017
 
4th Quarter 2016
 
3rd Quarter 2016
 
2nd Quarter 2016
 
1st Quarter 2016
 
Nine Months Ended
 
 
 
 
 
 
 
 
Sep 30,
2017
 
Sep 30,
2016
Efficiency Ratio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net interest income
$
143,628

 
$
137,948

 
$
130,097

 
$
132,447

 
$
96,809

 
$
77,495

 
$
74,330

 
$
411,673

 
$
248,634

Noninterest income
32,122

 
41,568

 
38,010

 
54,264

 
27,770

 
20,897

 
19,419

 
111,700

 
68,086

Total revenue - GAAP
175,750

 
179,516

 
168,107

 
186,711

 
124,579

 
98,392

 
93,749

 
523,373

 
316,720

Net interest income FTE adjustment
3,260

 
3,169

 
3,068

 
2,945

 
2,426

 
2,138

 
2,133

 
9,498

 
6,697

Loan servicing rights change in fair value (gains)losses
4,041

 
1,802

 
519

 
(6,348
)
 
1,236

 

 

 
6,362

 
1,236

Gain on sales of branch offices

 

 

 
(7,391
)
 

 

 

 

 

Gains from sale of investment securities and closed branch locations
(1
)
 
(77
)
 
(90
)
 
(76
)
 
(301
)
 
(123
)
 
(169
)
 
(168
)
 
(593
)
Total revenue - Non-GAAP
$
183,050

 
$
184,410

 
$
171,604

 
$
175,841

 
$
127,940

 
$
100,407

 
$
95,713

 
$
539,065

 
$
324,060

Operating expenses - GAAP
$
119,539

 
$
98,237

 
$
104,196

 
$
114,302

 
$
106,144

 
$
59,085

 
$
58,887

 
$
321,972

 
$
224,116

Merger and restructuring expenses
(21,203
)
 
(465
)
 
(4,167
)
 
(18,016
)
 
(37,470
)
 
(3,054
)
 
(2,594
)
 
(25,835
)
 
(43,118
)
Impairment of income tax credits
(3,095
)
 

 

 

 

 

 

 
(3,095
)
 

Operating expense, core - Non-GAAP
95,241

 
97,772

 
100,029

 
96,286

 
68,674

 
56,031

 
56,293

 
293,042

 
180,998

Amortization of intangibles
(1,526
)
 
(1,525
)
 
(1,513
)
 
(1,843
)
 
(1,292
)
 
(1,195
)
 
(1,194
)
 
(4,564
)
 
(3,681
)
Operating expenses, efficiency ratio - Non-GAAP
$
93,715

 
$
96,247

 
$
98,516

 
$
94,443

 
$
67,382

 
$
54,836

 
$
55,099

 
$
288,478

 
$
177,317

Efficiency ratio - GAAP
68.0
%
 
54.7
%
 
62.0
%
 
61.2
%
 
85.2
%
 
60.1
%
 
62.8
%
 
61.5
%
 
70.8
%
Efficiency ratio - adjusted Non-GAAP
51.2
%
 
52.2
%
 
57.4
%
 
53.7
%
 
52.7
%
 
54.6
%
 
57.6
%
 
53.5
%
 
54.7
%

 
Sep 30,
2017
 
June 30,
2017
 
March 31,
2017
 
Dec 31,
2016
 
Sep 30,
2016
 
June 30,
2016
 
March 31,
2016
Tangible Book Value
 
 
 
 
 
 
 
 
 
 
 
 
 
Shareholders' equity, as reported
$
2,673,089

 
$
2,639,442

 
$
2,600,051

 
$
2,581,526

 
$
2,563,666

 
$
1,050,299

 
$
1,032,291

Goodwill, CDI and noncompete agreements, net of tax
(1,153,576
)
 
(1,153,595
)
 
(1,154,915
)
 
(1,155,617
)
 
(1,154,121
)
 
(297,044
)
 
(297,821
)
Tangible shareholders' equity
$
1,519,513

 
$
1,485,847

 
$
1,445,136

 
$
1,425,909

 
$
1,409,545

 
$
753,255

 
$
734,470

Common shares outstanding
71,152

 
71,131

 
71,118

 
70,599

 
70,497

 
38,267

 
38,248

Book value per share (shareholders' equity, as reported, divided by common shares outstanding)
$
37.57

 
$
37.11

 
$
36.56

 
$
36.57

 
$
36.37

 
$
27.45

 
$
26.99

Tangible book value per share (tangible shareholders' equity divided by common shares outstanding)
$
21.36

 
$
20.89

 
$
20.32

 
$
20.20

 
$
19.99

 
$
19.68

 
$
19.20

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tangible Shareholders' Equity to Tangible Assets
 
 
 
 
 
 
 
 
 
 
Total assets, as reported
$
19,354,308

 
$
18,781,405

 
$
17,636,973

 
$
17,355,179

 
$
17,383,637

 
$
9,514,172

 
$
9,303,632

Goodwill, CDI and noncompete agreements, net of tax
(1,153,576
)
 
(1,153,595
)
 
(1,154,915
)
 
(1,155,617
)
 
(1,154,121
)
 
(297,044
)
 
(297,821
)
Tangible assets
$
18,200,732

 
$
17,627,810

 
$
16,482,058

 
$
16,199,562

 
$
16,229,516

 
$
9,217,128

 
$
9,005,811

Shareholders' equity to total assets
13.8
%
 
14.1
%
 
14.7
%
 
14.9
%
 
14.7
%
 
11.0
%
 
11.1
%
Tangible shareholders' equity to tangible assets
8.3
%
 
8.4
%
 
8.8
%
 
8.8
%
 
8.7
%
 
8.2
%
 
8.2
%

16